HIV-specific antibodies but not t-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia.

To study biological factors related to protection against HIV-1 infection in Cambodia, we recruited 48 partners of HIV-1-infected patients who remained uninfected (exposed uninfected individuals, EUs) despite unprotected sexual intercourse for more than 1 year and 49 unexposed controls (UCs). HIV-1-specific antibodies (IgA anti-gp41 and IgG anti-CD4-gp120 complex), T-cell responses, and cellular factors that may be involved in protection (peripheral blood mononuclear cell [PBMC] resistance to HIV-1 infection and beta-chemokine production) were evaluated. Anti-HIV-1 antibodies were higher in EUs than those in UCs (P = 0.01 and P = 0.04 for anti-gp41 and anti-CD4-gp120, respectively). We observed a decreased susceptibility to a primary Cambodian isolate, HIV-1KH019, in EU PBMCs as compared with UC PBMCs (P = 0.03). A weak T-cell response to one pool of HIV-1 Gag peptides was found by ELISpot in 1 of 19 EUs. Whereas T-cell specific immunity was not associated to protection, our results suggest that HIV-specific humoral immunity and reduced cell susceptibility to infection may contribute to protection against HIV-1 infection in Cambodian EUs.
AuthorsMarie Nguyen, Polidy Pean, Lucia Lopalco, Janin Nouhin, Viseth Phoung, Nary Ly, Pierre Vermisse, Yvette Henin, Françoise Barré-Sinoussi, Samuele E Burastero, Jean-Marc Reynes, Guislaine Carcelain, Gianfranco Pancino
JournalJournal of acquired immune deficiency syndromes (1999) (J Acquir Immune Defic Syndr) Vol. 42 Issue 4 Pg. 412-9 (Aug 1 2006) ISSN: 1525-4135 [Print] United States
PMID16837821 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HIV Antibodies
  • Adult
  • Cambodia
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HIV Antibodies (immunology)
  • HIV Infections (immunology)
  • HIV Seronegativity (immunology)
  • Humans
  • Male
  • Sexual Partners
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: